Accessibility: Skip TopNav
PRP Monotherapy Reprograms the Chemo-resistant State
PRP Monotherapy Reprograms the Chemo-resistant State and Enhances Chemotherapeutic Response in Pancreatic Cancer
Format
JPEG
Source
Propanc Biopharma, Inc.
Downloads
Original
Large
Medium
Small